Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,74%
1.094,84
+18,71
+1,74%
1.076,131.079,891.100,771.079,89
SIXC
Communications
SIXC
Communications
SIXC
-0,42%
604,21
-2,53
-0,42%
606,74606,74607,90602,03
SIXE
Energy
SIXE
Energy
SIXE
+0,07%
1.249,71
+0,89
+0,07%
1.248,821.246,371.256,421.239,08
SIXI
Industrials
SIXI
Industrials
SIXI
+0,86%
1.739,26
+14,90
+0,86%
1.724,361.733,021.745,751.727,76
SIXM
Financials
SIXM
Financials
SIXM
+0,01%
635,63
+0,040
+0,01%
635,59635,08637,96633,31
SIXR
Staples
SIXR
Staples
SIXR
+0,61%
848,32
+5,17
+0,61%
843,15842,50852,77840,85
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,22%
216,76
+0,47
+0,22%
216,29216,29217,30215,24
SIXT
Technology
SIXT
Technology
SIXT
+2,20%
3.335,14
+71,73
+2,20%
3.263,413.296,253.343,663.295,42
SIXU
Utilities
SIXU
Utilities
SIXU
+0,01%
939,34
+0,10
+0,01%
939,24941,57948,11939,11
SIXV
Health care
SIXV
Health care
SIXV
+0,38%
1.468,17
+5,61
+0,38%
1.462,561.465,031.471,561.459,66
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,28%
2.387,09
+6,69
+0,28%
2.380,402.394,922.412,132.386,82
ALKEM:NSE
Alkem Laboratories Ltd
₹5.603,00
+3,70%
(+200,00) 1D
6 ພ.ພ., 12 ໂມງ 14 ນາທີ 25 ວິນາທີ GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
₹5.405,00
High
₹5.635,50
Low
₹5.404,00
Mkt. cap
໖໖໙,໙໒ ຕື້
Avg. vol.
໑໐໖,໓໘ ພັນ
Volume
໗໗,໕໒ ພັນ
Dividend
໐,໙໑%
Quarterly dividend
₹12,75
Ex dividend date
14 ກ.ພ. 2025
P/E ratio
໒໘,໒໕
52-wk high
₹5.933,50
52-wk low
₹4.716,20
EPS
₹198,32
Shares outstanding
໑໑໙,໕໕ ລ້ານ
No. of employees
໑໙ ພັນ
News stories
From sources across the web
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees18,8 ພັນ
Founded1973
Headquartersມຸມໄບ, ມະຫາຣາສຈຕຣະ, ອິນເດຍ
SectorPharmaceutical industry
Last report
13 ກ.ພ. 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
໕໖,໘໘/ (໕໗,໙໗ est.)INR
-1,88%miss
Revenue / Estimate
໓໗,໓໗ ຕື້/ (໓໗,໖໑ ຕື້ est.)INR
-0,64%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
ມ.ນ. 2025
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
Revenue
31,44 ຕື້
33,71 ຕື້
40,01 ຕື້
37,37 ຕື້
Cost of goods sold
14,40 ຕື້
11,71 ຕື້
14,01 ຕື້
12,73 ຕື້
Cost of revenue
14,40 ຕື້
11,71 ຕື້
14,01 ຕື້
12,73 ຕື້
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,05 ຕື້
6,93 ຕື້
7,10 ຕື້
7,22 ຕື້
Operating expense
14,28 ຕື້
15,49 ຕື້
17,73 ຕື້
17,31 ຕື້
Total operating expenses
28,68 ຕື້
27,20 ຕື້
31,74 ຕື້
30,04 ຕື້
Operating income
2,76 ຕື້
6,51 ຕື້
8,27 ຕື້
7,33 ຕື້
Other non operating income
-3,24 ຕື້
1,36 ຕື້
1,04 ຕື້
1,43 ຕື້
EBT including unusual items
3,96 ຕື້
7,71 ຕື້
8,95 ຕື້
7,81 ຕື້
EBT excluding unusual items
3,36 ຕື້
7,58 ຕື້
8,95 ຕື້
8,33 ຕື້
Income tax expense
733,30 ລ້ານ
1,03 ຕື້
1,16 ຕື້
1,28 ຕື້
Effective tax rate
18,53%
13,33%
12,98%
16,35%
Other operating expenses
-894,30 ລ້ານ
7,68 ຕື້
9,69 ຕື້
9,15 ຕື້
Net income
3,06 ຕື້
6,64 ຕື້
7,65 ຕື້
6,36 ຕື້
Net profit margin
9,73%
19,70%
19,12%
17,02%
Earnings per share
25,57
54,62
63,99
56,88
Interest and investment income
3,59 ຕື້
-
-
-
Interest expense
-115,00 ລ້ານ
-297,80 ລ້ານ
-350,20 ລ້ານ
-421,00 ລ້ານ
Net interest expenses
3,47 ຕື້
-297,80 ລ້ານ
-350,20 ລ້ານ
-421,00 ລ້ານ
Depreciation and amortization charges
1,12 ຕື້
876,80 ລ້ານ
936,10 ລ້ານ
950,10 ລ້ານ
EBITDA
3,53 ຕື້
7,29 ຕື້
9,18 ຕື້
8,11 ຕື້
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more